Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBasic Science Investigations

PET Imaging of Very Late Antigen-4 in Melanoma: Comparison of 68Ga- and 64Cu-Labeled NODAGA and CB-TE1A1P-LLP2A Conjugates

Wissam Beaino and Carolyn J. Anderson
Journal of Nuclear Medicine November 2014, 55 (11) 1856-1863; DOI: https://doi.org/10.2967/jnumed.114.144881
Wissam Beaino
1Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carolyn J. Anderson
1Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania
2Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania; and
3Department of Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 55 no. 11 1856-1863
DOI 
https://doi.org/10.2967/jnumed.114.144881
PubMed 
25256059

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication June 24, 2014
  • Accepted for publication August 8, 2014
  • Published online November 3, 2014.

Article Versions

  • previous version (September 25, 2014 - 05:26).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2014 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Wissam Beaino1 and
  2. Carolyn J. Anderson1–3
  1. 1Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania
  2. 2Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania; and
  3. 3Department of Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania
  1. For correspondence or reprints contact: Carolyn J. Anderson, Department of Radiology, University of Pittsburgh, 100 Technology Dr., Suite 452, Pittsburgh, PA 15219. E-mail: andersoncj{at}upmc.edu
View Full Text

Statistics from Altmetric.com

Cited By...

  • 47 Citations
  • 49 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Tumor-targeting peptides from combinatorial libraries
    Ruiwu Liu, Xiaocen Li, Wenwu Xiao, Kit S. Lam
    Advanced Drug Delivery Reviews 2017 110-111
  • Noninvasive PET Imaging of T cells
    Weijun Wei, Dawei Jiang, Emily B. Ehlerding, Quanyong Luo, Weibo Cai
    Trends in Cancer 2018 4 5
  • Insight into the Development of PET Radiopharmaceuticals for Oncology
    Joseph Lau, Etienne Rousseau, Daniel Kwon, Kuo-Shyan Lin, François Bénard, Xiaoyuan Chen
    Cancers 2020 12 5
  • Positron Emission Tomography Imaging of Macaques with Tuberculosis Identifies Temporal Changes in Granuloma Glucose Metabolism and Integrin α4β1–Expressing Immune Cells
    Joshua T Mattila, Wissam Beaino, Pauline Maiello, M Teresa Coleman, Alexander G White, Charles A Scanga, JoAnne L Flynn, Carolyn J Anderson
    The Journal of Immunology 2017 199 2
  • Evaluation of 68Ga- and 177Lu-DOTA-PEG4-LLP2A for VLA-4-Targeted PET Imaging and Treatment of Metastatic Melanoma
    Wissam Beaino, Jessie R. Nedrow, Carolyn J. Anderson
    Molecular Pharmaceutics 2015 12 6
  • PET and SPECT imaging of melanoma: the state of the art
    Weijun Wei, Emily B. Ehlerding, Xiaoli Lan, Quanyong Luo, Weibo Cai
    European Journal of Nuclear Medicine and Molecular Imaging 2018 45 1
  • Ex Vivo and In Vivo Evaluation of Overexpressed VLA-4 in Multiple Myeloma Using LLP2A Imaging Agents
    Deepti Soodgupta, Haiying Zhou, Wissam Beaino, Lan Lu, Michael Rettig, Mark Snee, James Skeath, John F. DiPersio, Walter J. Akers, Richard Laforest, Carolyn J. Anderson, Michael H. Tomasson, Monica Shokeen
    Journal of Nuclear Medicine 2016 57 4
  • Increasing the Net Negative Charge by Replacement of DOTA Chelator with DOTAGA Improves the Biodistribution of Radiolabeled Second-Generation Synthetic Affibody Molecules
    Kristina Westerlund, Hadis Honarvar, Emily Norrström, Joanna Strand, Bogdan Mitran, Anna Orlova, Amelie Eriksson Karlström, Vladimir Tolmachev
    Molecular Pharmaceutics 2016 13 5
  • Withaferin A inhibits in vivo growth of breast cancer cells accelerated by Notch2 knockdown
    Su-Hyeong Kim, Eun-Ryeong Hahm, Julie A. Arlotti, Suman K. Samanta, Michelle B. Moura, Stephen H. Thorne, Yongli Shuai, Carolyn J. Anderson, Alexander G. White, Anna Lokshin, Joomin Lee, Shivendra V. Singh
    Breast Cancer Research and Treatment 2016 157 1
  • A Metal-Free DOTA-Conjugated 18F-Labeled Radiotracer: [18F]DOTA-AMBF3-LLP2A for Imaging VLA-4 Over-Expression in Murine Melanoma with Improved Tumor Uptake and Greatly Enhanced Renal Clearance
    Áron Roxin, Chengcheng Zhang, Sungjoon Huh, Mathieu Lepage, Zhengxing Zhang, Kuo-Shyan Lin, François Bénard, David M. Perrin
    Bioconjugate Chemistry 2019 30 4

Article usage

Article usage: September 2014 to April 2025

AbstractFullPdf
Sep 2014237040
Oct 2014295057
Nov 20145752959
Dec 20141392226
Jan 20151221623
Feb 2015691213
Mar 2015981013
Apr 2015472424
May 2015582526
Jun 2015492015
Jul 2015311622
Aug 2015361515
Sep 2015542015
Oct 2015201215
Nov 2015441610
Dec 201546810
Jan 2016661226
Feb 2016231119
Mar 2016241324
Apr 201613610
May 201622514
Jun 2016251212
Jul 20161645
Aug 201621713
Sep 201628135
Oct 201623814
Nov 2016371325
Dec 2016351220
Jan 201721107
Feb 201718614
Mar 20172498
Apr 201717210
May 201720612
Jun 20171589
Jul 20178410
Aug 201722126
Sep 20172699
Oct 20171466
Nov 201714148
Dec 20171377
Jan 201811521
Feb 20181486
Mar 20181365
Apr 20181874
May 2018987
Jun 20181765
Jul 20181636
Aug 2018966
Sep 2018412
Oct 20186117
Nov 2018545
Dec 20181157
Jan 2019938
Feb 2019814
Mar 20199512
Apr 2019749
May 20191278
Jun 201911913
Jul 201917718
Aug 20196417
Sep 201912726
Oct 2019162435
Nov 20199212
Dec 20196118
Jan 20209213
Feb 20201147
Mar 2020947
Apr 20201857
May 20208519
Jun 2020829
Jul 2020915
Aug 20206811
Sep 2020855
Oct 20202546
Nov 202012312
Dec 2020987
Jan 2021898
Feb 2021132014
Mar 2021142126
Apr 202181522
May 202192317
Jun 202161810
Jul 202151518
Aug 202151924
Sep 202161417
Oct 202181430
Nov 202191129
Dec 202192410
Jan 2022678
Feb 202281412
Mar 202232716
Apr 2022277
May 202251411
Jun 202281314
Jul 20220165
Aug 20225168
Sep 202211311
Oct 20221178
Nov 202241112
Dec 20223135
Jan 202392515
Feb 202321912
Mar 202393120
Apr 202331610
May 202342621
Jun 20234206
Jul 202382113
Aug 202341611
Sep 20232298
Oct 202357811
Nov 202371409
Dec 20230295
Jan 202410149
Feb 20246148
Mar 202401739
Apr 202482433
May 2024132913
Jun 202443514
Jul 202454520
Aug 202484112
Sep 20248208
Oct 202492412
Nov 202472218
Dec 202433410
Jan 202522915
Feb 2025146116
Mar 2025115833
Apr 202563328
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 55 (11)
Journal of Nuclear Medicine
Vol. 55, Issue 11
November 1, 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
PET Imaging of Very Late Antigen-4 in Melanoma: Comparison of 68Ga- and 64Cu-Labeled NODAGA and CB-TE1A1P-LLP2A Conjugates
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
PET Imaging of Very Late Antigen-4 in Melanoma: Comparison of 68Ga- and 64Cu-Labeled NODAGA and CB-TE1A1P-LLP2A Conjugates
Wissam Beaino, Carolyn J. Anderson
Journal of Nuclear Medicine Nov 2014, 55 (11) 1856-1863; DOI: 10.2967/jnumed.114.144881

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
PET Imaging of Very Late Antigen-4 in Melanoma: Comparison of 68Ga- and 64Cu-Labeled NODAGA and CB-TE1A1P-LLP2A Conjugates
Wissam Beaino, Carolyn J. Anderson
Journal of Nuclear Medicine Nov 2014, 55 (11) 1856-1863; DOI: 10.2967/jnumed.114.144881
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • 18F-PFPN PET: A New and Attractive Imaging Modality for Patients with Malignant Melanoma
  • Advances in Receptor-Targeted Radiolabeled Peptides for Melanoma Imaging and Therapy
  • Molecular Imaging of Very Late Antigen-4 in Acute Lung Injury
  • Positron Emission Tomography Imaging of Macaques with Tuberculosis Identifies Temporal Changes in Granuloma Glucose Metabolism and Integrin {alpha}4{beta}1-Expressing Immune Cells
  • Ex Vivo and In Vivo Evaluation of Overexpressed VLA-4 in Multiple Myeloma Using LLP2A Imaging Agents
  • Google Scholar

More in this TOC Section

  • Tumor-Specific Binding of Radiolabeled PEGylated GIRLRG Peptide: A Novel Agent for Targeting Cancers
  • PET/MRI of Hypoxic Atherosclerosis Using 64Cu-ATSM in a Rabbit Model
  • Tumor Uptake of Anti-CD20 Fabs Depends on Tumor Perfusion
Show more Basic Science Investigations

Similar Articles

Keywords

  • LLP2A
  • melanoma
  • VLA-4
  • PET
  • metastasis
SNMMI

© 2025 SNMMI

Powered by HighWire